Augustine Lawlor, Director at Gyre Therapeutics, holds 683.54K shares in Leap Therapeutics (Ticker: LPTX), holds 0.00 shares in Gyre Therapeutics (Ticker: GYRE), holds 0.00 shares in Cardiovascular Systems (Ticker: CSII). Most recently, Augustine Lawlor Bought ― shares of Leap Therapeutics on Nov 15, 2024 for an estimated value of 6.02K.
Augustine Lawlor latest transaction was an Informative Buy of $6.02K.
What was Augustine Lawlor's most profitable transaction?
Augustine Lawlor’s most profitable transaction was an Informative Sell of GBIM stock on February 24, 2016. The return on the trade was 84.80%.
What is Augustine Lawlor's role in Gyre Therapeutics?
Augustine Lawlor's role in Gyre Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.